Geneva Capital Management’s Protolabs PRLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-261,208
Closed -$24M 129
2021
Q2
$24M Sell
261,208
-8,230
-3% -$811K 0.39% 92
2021
Q1
$32.8M Sell
269,438
-139,973
-34% -$23.3M 0.56% 77
2020
Q4
$62.8M Sell
409,411
-22,152
-5% -$3.12M 1.06% 35
2020
Q3
$55.9M Buy
431,563
+10,658
+3% +$1.4M 1.15% 31
2020
Q2
$47.3M Buy
420,905
+14,464
+4% +$1.48M 1.02% 37
2020
Q1
$30.9M Buy
+406,441
New +$37.7M 0.88% 52
2014
Q3
$10.1M Sell
146,471
-2,432
-2% -$190K 0.3% 93
2014
Q2
$12.2M Buy
148,903
+9,367
+7% +$634K 0.3% 91
2014
Q1
$9.44M Sell
139,536
-624
-0.4% -$46.4K 0.22% 98
2013
Q4
$9.98M Sell
140,160
-6,445
-4% -$500K 0.23% 97
2013
Q3
$11.2M Buy
+146,605
New +$10.1M 0.27% 91

Other funds holding PRLB

Geneva Capital Management's PRLB Position: Q3 2021 in Review

Geneva Capital Management sold out of Protolabs (PRLB) in Q3 2021, closing a stake of 261,208 shares — an estimated $24M sold.

Geneva Capital Management first reported a position in PRLB in Q3 2013 and held it in 11 quarters. The position peaked at $62.8M in Q4 2020. 263 funds tracked by Wall St. Rank hold PRLB as of Q3 2021.

  • Geneva Capital Management reported no remaining Protolabs position as of Q3 2021 after selling out during the quarter.
  • Geneva Capital Management sold 261,208 Protolabs shares in Q3 2021, an estimated $24M.
  • Geneva Capital Management first reported a position in Protolabs in Q3 2013 and held it in 11 quarters.
  • Geneva Capital Management's Protolabs position peaked at $62.8M in Q4 2020.
  • 263 funds tracked by Wall St. Rank held Protolabs as of Q3 2021.

Based on Geneva Capital Management's 13F filing for Q3 2021, filed 8 Nov 2021.